Novel oxazole and thiazole compounds as transforming growth factor (TGF) inhibitors
申请人:Pfizer Inc
公开号:US20040110797A1
公开(公告)日:2004-06-10
Novel oxazole and thiazole compounds, including derivatives thereof, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use are described. The compounds of the present invention are potent inhibitors of transforming growth factor (“TGF”)-&bgr; signaling pathway. They are useful in the treatment of various TGF-related disease states including, for example, cancer and fibrotic diseases.
本发明涉及新型噁唑和噻唑化合物,包括其衍生物,以及制备它们的中间体,含有它们的制药组合物以及它们的药用用途。本发明所述化合物是转化生长因子(“TGF”)-β信号通路的有效抑制剂。它们可用于治疗各种与TGF相关的疾病状态,包括例如癌症和纤维化疾病。